Capital Research Global Investors Gsk PLC Transaction History

Capital Research Global Investors

10 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$42.05 - $47.77 $53,277 - $60,524	-1,267 Reduced 0.02%	5,567,697 $242 Million
Q1 2022 May 16, 2022	BUY	$40.23 - $47.74 $8,126 - $9,643	202 Added 0.0%	5,568,964 $243 Million
Q4 2021 Feb 14, 2022	SELL	$38.88 - $45.31 $29,315 - $34,163	-754 Reduced 0.01%	5,568,762 $246 Million
Q3 2021 Nov 15, 2021	BUY	$38.79 - $43.16 $27,812 - $30,945	717 Added 0.01%	5,569,516 $213 Million
Q2 2021 Aug 16, 2021	SELL	$36.52 - $41.46 $5.37 Million - $6.1 Million	-147,110 Reduced 2.57%	5,568,799 $222 Million
Q1 2021 May 14, 2021	BUY	$34.27 - $40.01 $35,195 - $41,090	1,027 Added 0.02%	5,715,909 $204 Million
Q4 2020 Feb 12, 2021	BUY	$34.07 - $39.94 $24.6 Million - $28.8 Million	721,128 Added 14.44%	5,714,882 $210 Million
Q3 2020 Nov 13, 2020	BUY	$38.11 - $42.99 $13.9 Million - $15.6 Million	363,859 Added 7.86%	4,993,754 $188 Million
Q2 2020 Aug 14, 2020	BUY	$37.87 - $43.58 $175 Million - $202 Million	4,629,696 Added 2326480.5%	4,629,895 $189 Million
Q1 2020 May 15, 2020	BUY	$32.47 - $48.83 $6,461 - $9,717	199 New	199 $7,000

176K

Ticker GSK
Exchange OTC
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,033,689,984
Market Cap $67.3B
Description
GSK plc, together with its subsidiaries, engages in the creation, discovery, development, manufacture, and marketing of pharmaceutical products, vaccines, over-the-counter medicines, and health-related consumer products in the United Kingdom, the United States, and internationally. It operates through four segments: Pharmaceuticals, Pharmaceutic...

Get notified when there are updates to the investment portfolio of Capital Research Global Investors, based on Form 13F filings with the SEC.

Stay updated on Capital Research Global Investors with notifications on news.